The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT.

Fluorodeoxyglucose F18 Humans Positron Emission Tomography Computed Tomography / methods Practice Guidelines as Topic Predictive Value of Tests Radiopharmaceuticals
False-negative Intervention Methodology Positron emission tomography Protocol

Journal

Cancer imaging : the official publication of the International Cancer Imaging Society
ISSN: 1470-7330
Titre abrégé: Cancer Imaging
Pays: England
ID NLM: 101172931

Informations de publication

Date de publication:
22 Sep 2020
Historique:
received: 23 04 2020
accepted: 14 09 2020
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 15 12 2020
Statut: epublish

Résumé

Positron Emission Tomography with Computed Tomography (PET/CT) is widely used in the assessment of many diseases, particularly including cancer. However, many factors can affect image quality and diagnostic performance of PET scans using FDG or other PET probes. The aim of this pictorial essay is to review PET/CT protocols that can be useful to overcome these confounding factors in routine clinical situations, with a particular focus on pharmacological interventions and problem-oriented CT acquisition protocols. Imaging protocols and representative cases will be discussed, in addition to potential contraindications and precautions to be taken.

Sections du résumé

BACKGROUND BACKGROUND
Positron Emission Tomography with Computed Tomography (PET/CT) is widely used in the assessment of many diseases, particularly including cancer. However, many factors can affect image quality and diagnostic performance of PET scans using FDG or other PET probes.
MAIN BODY METHODS
The aim of this pictorial essay is to review PET/CT protocols that can be useful to overcome these confounding factors in routine clinical situations, with a particular focus on pharmacological interventions and problem-oriented CT acquisition protocols.
CONCLUSION CONCLUSIONS
Imaging protocols and representative cases will be discussed, in addition to potential contraindications and precautions to be taken.

Identifiants

DOI: 10.1186/s40644-020-00344-9 PMID: 32962752 PMC: PMC7510123
pubmed: 32962752
doi: 10.1186/s40644-020-00344-9
pii: 10.1186/s40644-020-00344-9
pmc: PMC7510123
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

68

Références

Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1815-8
pubmed: 17546453
Nucl Med Commun. 2009 Jun;30(6):431-9
pubmed: 19352209
J Nucl Med. 2005 Jun;46(6):953-7
pubmed: 15937305
Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):90-6
pubmed: 20857098
Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):386-93
pubmed: 23179944
Cancer Imaging. 2017 Dec 20;17(1):30
pubmed: 29262870
J Nucl Med. 2004 Jul;45(7):1189-93
pubmed: 15235065
Blood. 2005 Oct 15;106(8):2710-5
pubmed: 15985543
J Nucl Med. 2006 Jun;47(6):1059-66
pubmed: 16741317
Cancer Imaging. 2016 Aug 17;16(1):22
pubmed: 27535829
J Nucl Med. 2006 May;47(5):885-95
pubmed: 16644760
Cancer Imaging. 2016 Oct 18;16(1):35
pubmed: 27756360
Cancer. 2007 Jan 1;109(1):117-24
pubmed: 17133406
J Nucl Med. 2006 Nov;47(11):1803-7
pubmed: 17079813
J Nucl Med. 2016 Apr;57(4):568-73
pubmed: 26659348
Radiology. 2018 Nov;289(2):418-425
pubmed: 30106348
Cancer Imaging. 2006 Oct 31;6:S52-62
pubmed: 17114079
Cancer Imaging. 2018 Apr 26;18(1):15
pubmed: 29695290
PET Clin. 2020 Jan;15(1):11-22
pubmed: 31735298
Pediatr Hematol Oncol. 2017 Apr;34(3):149-156
pubmed: 28727480
Eur J Radiol. 2020 Aug;129:109144
pubmed: 32593080
Mol Imaging Biol. 2006 Nov-Dec;8(6):348-54
pubmed: 17053859
J Nucl Med. 1998 Jun;39(6):1030-3
pubmed: 9627339
Clin Positron Imaging. 1999 Oct;2(5):281-287
pubmed: 14516652
Nucl Med Commun. 2015 Feb;36(2):180-6
pubmed: 25321162
Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1818-9
pubmed: 24893789
Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):644-53
pubmed: 26487512
J Nucl Med. 2007 May;48(5):764-70
pubmed: 17475965
Pediatr Radiol. 2005 Oct;35(10):984-90
pubmed: 15988582
AJR Am J Roentgenol. 2010 Dec;195(6):1404-10
pubmed: 21098202
J Nucl Med. 1993 Jan;34(1):1-6
pubmed: 8418248
Cancer Imaging. 2017 Dec 21;17(1):31
pubmed: 29268784
Cancer Imaging. 2019 Aug 19;19(1):57
pubmed: 31426862
Ann Nucl Med. 2016 Nov;30(9):629-636
pubmed: 27392947
EJNMMI Res. 2019 Feb 8;9(1):15
pubmed: 30737563
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219

Auteurs

David Dudoignon (D)

The Department of Nuclear Medicine, University Hospital, Caen, France.

David A Pattison (DA)

Department of Nuclear Medicine & Specialised PET Services, Royal Brisbane and Women's Hospital, Herston, Australia.
School of Medicine, University of Queensland, Brisbane, Australia.

Damien Legallois (D)

The Department of Cardiology, University Hospital, Caen, France.

Rodney J Hicks (RJ)

The Department of Molecular Imaging and Therapeutic Nuclear Medicine, the Peter MacCallum Cancer Institute, Melbourne, Australia.
The Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, Australia.

Nicolas Aide (N)

The Department of Nuclear Medicine, University Hospital, Caen, France. aide-n@chu-caen.fr.
INSERM ANTICIPE, Normandie University, Caen, France. aide-n@chu-caen.fr.
ORCID: 0000-0001-9207-0847

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Glucides › Désoses › Désoxyglucose › Fluorodésoxyglucose F18 › The utility of pharmacological and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The utility of pharmacological and...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › The utility of pharmacological and...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › The utility of pharmacological and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Valeur prédictive des tests › The utility of pharmacological and...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › The utility of pharmacological and...